206 related articles for article (PubMed ID: 28078827)
1. FAM83 family oncogenes are broadly involved in human cancers: an integrative multi-omics approach.
Snijders AM; Lee SY; Hang B; Hao W; Bissell MJ; Mao JH
Mol Oncol; 2017 Feb; 11(2):167-179. PubMed ID: 28078827
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of the expression, prognostic significance, and function of FAM83 family members in breast cancer.
Jin Y; Yu J; Jiang Y; Bu J; Zhu T; Gu X; Zhu X
World J Surg Oncol; 2022 Jun; 20(1):172. PubMed ID: 35650627
[TBL] [Abstract][Full Text] [Related]
3. Identification of Prognostic and Therapeutic Biomarkers among FAM83 Family Members for Pancreatic Ductal Adenocarcinoma.
Ma Z; Zhou Z; Zhuang H; Li Z; Ma Z; Huang B; Liu C; Gong Y; Zou Y; Zheng Z; Huang S; Zhang C; Hou B
Dis Markers; 2021; 2021():6682697. PubMed ID: 33747255
[TBL] [Abstract][Full Text] [Related]
4. Conserved oncogenic behavior of the FAM83 family regulates MAPK signaling in human cancer.
Cipriano R; Miskimen KL; Bryson BL; Foy CR; Bartel CA; Jackson MW
Mol Cancer Res; 2014 Aug; 12(8):1156-65. PubMed ID: 24736947
[TBL] [Abstract][Full Text] [Related]
5. Identification of Prognostic Biomarkers Among FAM83 Family Genes in Human Ovarian Cancer Through Bioinformatic Analysis and Experimental Verification.
Lin S; Du J; Hao J; Luo X; Wu H; Zhang H; Zhao X; Xu L; Wang B
Cancer Manag Res; 2021; 13():8611-8627. PubMed ID: 34815715
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive Analysis and Identification of Prognostic Biomarkers and Therapeutic Targets Among FAM83 Family Members for Gastric Cancer.
Zhang T; Lai S; Cai Y; Huang Z; Li Y; Chen S; Zhang Z; Ye Z; Lai X; Zhai E; Cai S; Chen J
Front Cell Dev Biol; 2021; 9():719613. PubMed ID: 34869310
[No Abstract] [Full Text] [Related]
7. FAM83 proteins: Fostering new interactions to drive oncogenic signaling and therapeutic resistance.
Bartel CA; Parameswaran N; Cipriano R; Jackson MW
Oncotarget; 2016 Aug; 7(32):52597-52612. PubMed ID: 27221039
[TBL] [Abstract][Full Text] [Related]
8. Pan-cancer analysis of the FAM83 family and its association with prognosis and tumor microenvironment.
Yuan S; Huang Z; Qian X; Wang Y; Fang C; Chen R; Zhang X; Xiao Z; Wang Q; Yu B; Li Y
Front Genet; 2022; 13():919559. PubMed ID: 35938024
[TBL] [Abstract][Full Text] [Related]
9. Systematic Analysis of Expression Profiles and Prognostic Significance for
Gan J; Li Y; Meng Q
Front Mol Biosci; 2020; 7():572406. PubMed ID: 33363204
[TBL] [Abstract][Full Text] [Related]
10. The DUF1669 domain of FAM83 family proteins anchor casein kinase 1 isoforms.
Fulcher LJ; Bozatzi P; Tachie-Menson T; Wu KZL; Cummins TD; Bufton JC; Pinkas DM; Dunbar K; Shrestha S; Wood NT; Weidlich S; Macartney TJ; Varghese J; Gourlay R; Campbell DG; Dingwell KS; Smith JC; Bullock AN; Sapkota GP
Sci Signal; 2018 May; 11(531):. PubMed ID: 29789297
[TBL] [Abstract][Full Text] [Related]
11. Involvement of FAM83 Family Proteins in the Development of Solid Tumors: An Update Review.
Jiang Y; Yu J; Zhu T; Bu J; Hu Y; Liu Y; Zhu X; Gu X
J Cancer; 2023; 14(10):1888-1903. PubMed ID: 37476189
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide association analysis identifies genetic correlates of immune infiltrates in solid tumors.
Siemers NO; Holloway JL; Chang H; Chasalow SD; Ross-MacDonald PB; Voliva CF; Szustakowski JD
PLoS One; 2017; 12(7):e0179726. PubMed ID: 28749946
[TBL] [Abstract][Full Text] [Related]
13. [Lung cancer molecular testing, what role for Next Generation Sequencing and circulating tumor DNA].
Pécuchet N; Legras A; Laurent-Puig P; Blons H
Ann Pathol; 2016 Jan; 36(1):80-93. PubMed ID: 26803564
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of FAM83D gene expression across human cancer types.
Walian PJ; Hang B; Mao JH
Oncotarget; 2016 Jan; 7(3):3332-40. PubMed ID: 26678035
[TBL] [Abstract][Full Text] [Related]
15. The FAM83 family of proteins: from pseudo-PLDs to anchors for CK1 isoforms.
Bozatzi P; Sapkota GP
Biochem Soc Trans; 2018 Jun; 46(3):761-771. PubMed ID: 29871876
[TBL] [Abstract][Full Text] [Related]
16. Integrative modeling of multi-omics data to identify cancer drivers and infer patient-specific gene activity.
Pavel AB; Sonkin D; Reddy A
BMC Syst Biol; 2016 Feb; 10():16. PubMed ID: 26864072
[TBL] [Abstract][Full Text] [Related]
17. A pan-cancer study of copy number gain and up-regulation in human oncogenes.
Wee Y; Wang T; Liu Y; Li X; Zhao M
Life Sci; 2018 Oct; 211():206-214. PubMed ID: 30243646
[TBL] [Abstract][Full Text] [Related]
18. FAM83A and FAM83B as Prognostic Biomarkers and Potential New Therapeutic Targets in NSCLC.
Richtmann S; Wilkens D; Warth A; Lasitschka F; Winter H; Christopoulos P; Herth FJF; Muley T; Meister M; Schneider MA
Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31083571
[TBL] [Abstract][Full Text] [Related]
19. Targets of genome copy number reduction in primary breast cancers identified by integrative genomics.
Chen W; Salto-Tellez M; Palanisamy N; Ganesan K; Hou Q; Tan LK; Sii LH; Ito K; Tan B; Wu J; Tay A; Tan KC; Ang E; Tan BK; Tan PH; Ito Y; Tan P
Genes Chromosomes Cancer; 2007 Mar; 46(3):288-301. PubMed ID: 17171680
[TBL] [Abstract][Full Text] [Related]
20. A comprehensive overview of oncogenic pathways in human cancer.
Li F; Wu T; Xu Y; Dong Q; Xiao J; Xu Y; Li Q; Zhang C; Gao J; Liu L; Hu X; Huang J; Li X; Zhang Y
Brief Bioinform; 2020 May; 21(3):957-969. PubMed ID: 31155677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]